Figure 6.
SRI response in serologically active patients (anti-dsDNA positive with low complement).
Solid lines, belimumab 10 mg/kg; dashed lines, placebo.
SRI: Systemic Lupus Erythematosus Responder Index; anti-dsDNA: anti-double-stranded DNA.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.